bioRxiv preprint doi: https://doi.org/10.1101/220699; this version posted July 15, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Running Title: Neurotransmitter metabolism in Alzheimer’s brain Neurotransmitter imbalance in the brain and Alzheimer’s pathology. Stuart G. Snowdena, Amera A. Ebshianaa, Abdul Hyeb, Olga Pletnikovac, Richard O’Briend, An Yange, John Troncosoc, Cristina Legido-Quigleya*, Madhav Thambisettye*. a Institute of Pharmaceutical Sciences, King’s College London, Franklin-Wilkins Building, 150 Stamford Street, London, SE1 9NH, UK. b Institute of Psychiatry, Psychology and Neuroscience, Department of Old Age Psychiatry, King’s College London, Maurice Wohl Clinical Neuroscience Institute, 125 Coldharbour Lane, SE5 9NU, UK. c Division of Neuropathology Johns Hopkins School of Medicine 720 Rutland Avenue, Ross 558 Baltimore, MD 21205, USA. d Department of Neurology, Duke University Medical School, USA. e Clinical and Translational Neuroscience Unit, Laboratory of Behavioural Neuroscience, National Institute on Aging, Baltimore, MD, USA. * Corresponding Authors
[email protected] Institute of Pharmaceutical Sciences, King’s College London, Franklin-Wilkins Building, 150 Stamford Street, London, SE1 9NH, UK.
[email protected] Clinical and Translational Neuroscience Unit, Laboratory of Behavioural Neuroscience, National Institute on Aging, Baltimore, MD, USA. This research did not receive any specific grant from funding agencies in the public, commercial or not-for-profit sectors. 1 bioRxiv preprint doi: https://doi.org/10.1101/220699; this version posted July 15, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder.